Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
DTC Test Results Don’t Lead to Dramatic Changes in Health Care Use
...
Already a member? Log in here
FDA’s 2017 Priorities Emphasize Biomarkers and Precision Diagnostics
From - Diagnostic Testing & Emerging Technologies
Precision medicine and biomarkers can help the U.S. Food and Drug Administration (FDA) ensure safety of…
Studies Address Impact of DTC Genetic Testing
From - Diagnostic Testing & Emerging Technologies
Consumers buying direct-to-consumer personal genome tests (DTC-PGT) want to believe…
How Meaningful are Results of Testing a Drop of Blood?
From - Diagnostic Testing & Emerging Technologies
With Theranos' recent announcement of its transition away from laboratory operations toward technology development…
Update on Zika-Fighting Diagnostics
From - Diagnostic Testing & Emerging Technologies
Summer may be over but the fight against the mosquito-borne virus, Zika, continues in earnest. Locally-mosquito-transmitted cases in…
Genetic Testing: More Options Require More Education
From - Diagnostic Testing & Emerging Technologies
Increasing diagnostic options for providers and patients was a common theme throughout panel discussions and presentations at…
Public Ahead of Providers in Support for Personalized Medicine
...
Already a member? Log in here